Complication of intramuscular/subcutaneous immune therapy in severely immune-compromised individuals.
Picard
O
O
Lebas
J
J
Imbert
J C
JC
Bigel
P
P
Zagury
D
D
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000628:therapy*; D015496:CD4-Positive T-Lymphocytes; D015488:HIV Antigens; D006801:Humans; D016233:Immunotherapy, Active / Q000009:adverse effects*; D007273:Injections, Intramuscular / Q000009:adverse effects; D007279:Injections, Subcutaneous / Q000009:adverse effects; D009336:Necrosis; D012867:Skin / Q000473:pathology; D014614:Vaccines, Synthetic / Q000009:adverse effects; D014765:Viral Vaccines / Q000009:adverse effects*
D015488:HIV Antigens; D014614:Vaccines, Synthetic; D014765:Viral Vaccines